A cutoff level is the concentration of a drug or drug metabolite in a specimen — expressed in nanograms per milliliter (ng/mL) — above which a test reports a positive (non-negative) result and below which it reports a negative result. Cutoffs exist because trace amounts of many substances can appear in urine from passive exposure, cross-reactive compounds, or legal medications, and a threshold prevents those incidental traces from generating false-positive outcomes. Understanding how cutoffs are set, and why they differ between test types, is essential for any program administrator making purchasing or policy decisions.
<!-- IMAGE: diagram showing a horizontal scale with "negative zone" on the left and "positive zone" on the right, with a vertical cutoff threshold line labeled in ng/mL -->Why cutoff levels matter for your program
When a specimen's concentration falls below the cutoff, the test result is negative — regardless of whether any drug is technically detectable. When concentration is at or above the cutoff, the result is reported as non-negative (presumptive positive on an instant test, or positive after laboratory confirmation).
This has two practical implications for program administrators:
- Sensitivity vs. specificity trade-off. A lower cutoff catches more use — including light or historic use — but also increases the chance of a non-negative result that requires a confirmatory follow-up. A higher cutoff reduces noise but may miss infrequent users.
- Cutoff selection affects deterrence. Programs focused on active impairment may prefer higher cutoffs; abstinence-based programs (sober living, court-ordered monitoring) often benefit from lower cutoffs that detect even minimal recent use.
Screening cutoffs vs. confirmation cutoffs
Instant (immunoassay) tests use a screening cutoff. Laboratory confirmation — typically via gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–mass spectrometry (LC-MS/MS) — uses a separate, lower confirmation cutoff. The confirmation threshold is intentionally set lower than the screening threshold to avoid a scenario where a specimen that screened positive falls below the confirmatory cutoff due to assay variability.
A result is only reportable as confirmed positive when the specimen concentration meets or exceeds the confirmation cutoff in the laboratory analysis. If it does not, the specimen may be reported as negative by the lab even though the instant screen was non-negative. This is not a product defect — it reflects the deliberate two-tiered design of the testing process.
How cutoffs are established
Cutoffs are set by device manufacturers based on validation studies and, for federally regulated programs, by government bodies. The key reference framework in the United States is the SAMHSA Mandatory Guidelines, which establish both screening and confirmation cutoffs for federal workplace testing programs. Non-regulated programs are not legally required to follow SAMHSA cutoffs, but many programs adopt them as a defensible baseline.
For more background on the SAMHSA framework, see the related resource on SAMHSA cutoffs.
Individual manufacturers may offer products with non-standard cutoffs — for example, a lower THC cutoff for abstinence monitoring or a higher opiate cutoff to reduce false positives from poppy-seed ingestion. Always verify the cutoff printed on the device packaging or package insert for the specific product you purchase, as cutoffs are product-specific and can vary even within the same drug class across different SKUs.
Step-by-step: how to evaluate cutoffs when selecting a test
- Identify your regulatory framework. Are you running a DOT-regulated program, a federal workplace program, a clinical program, or a non-regulated employer program? DOT and federally mandated programs must follow specific cutoff requirements. Non-regulated programs have more flexibility.
- Define your program's sensitivity goal. Abstinence-based programs (rehab, sober living, probation) often prefer lower cutoffs. General pre-employment screening often follows standard thresholds.
- Review the package insert for each analyte. The cutoff is stated per drug per product — do not assume all panels from the same manufacturer share identical cutoffs.
- Check whether a dual-cutoff option exists for any analyte. Some products offer two cutoff levels for a single analyte (e.g., opiates at 300 ng/mL and 2,000 ng/mL) to help distinguish therapeutic use from illicit use.
- Confirm your confirmation lab's cutoffs. If non-negative screens will be sent for laboratory confirmation, ask your lab what confirmation thresholds they use. Ensure alignment between your screening product and the lab's process.
- Document your cutoff rationale. For any regulated or legally consequential program, record why you selected the cutoffs you did. This supports defensibility in disputes.
Common mistakes and gotchas
- Assuming all panels have the same cutoffs. A 12-panel cup and a 12-panel dip card — even from the same manufacturer — may have different cutoffs for certain analytes. Verify per product.
- Confusing screening positives with confirmed positives. A non-negative instant result is presumptive only. Never take adverse action based solely on an unconfirmed instant screen in programs that require confirmation.
- Overlooking specimen validity. Dilute specimens reduce the effective concentration of metabolites, which can push a borderline result below the cutoff and yield a false negative. Adulterant detection and specimen validity testing address this risk.
- Applying SAMHSA cutoffs to non-urine specimens. SAMHSA cutoffs are defined for urine. Oral fluid (saliva) tests operate under different cutoff standards — verify with the manufacturer.
- Neglecting to update cutoffs when adding new analytes. When expanding a panel (e.g., adding fentanyl or kratom), confirm that the cutoff for the new analyte fits your program's clinical or policy intent.
- Treating detection windows as fixed. Cutoffs interact with detection windows: a higher cutoff shortens the practical window in which a drug can be detected, even if the drug is still present at sub-cutoff concentrations. Detection times also vary by individual, dose, frequency of use, hydration, and metabolism.
Recommended products
Magenta offers instant urine test cups and dip cards across a wide range of panel configurations. For abstinence-monitoring environments where lower cutoffs or specialty analytes matter, explore:
- Drug test cups — integrated urine cups in 5- through 20-panel configurations
- Drug test dip cards — flexible dip-card formats including specialty analyte options
- Specialty tests — individual strips for fentanyl, kratom, xylazine, and other analytes where cutoff precision is critical
- Oral fluid (saliva) drug tests — for programs requiring an alternative specimen type with its own cutoff framework
If you are running a program with specific regulatory requirements, the DOT Transportation and Workplace HR industry pages provide relevant context for your purchasing decisions.
Frequently asked questions
What does ng/mL mean on a drug test?
ng/mL stands for nanograms per milliliter — it is the unit used to express the concentration of a drug or its metabolite in a urine specimen. Cutoff levels are stated in ng/mL, and a result is reported as non-negative when the specimen concentration meets or exceeds that threshold.
Are instant test cutoffs the same as lab confirmation cutoffs?
No. Immunoassay (instant) screening cutoffs and laboratory confirmation cutoffs are separate thresholds, and the confirmation cutoff is typically set lower. A specimen must meet or exceed the confirmation cutoff in lab analysis to be reported as a confirmed positive — even if it triggered a non-negative on the instant screen.
Do I have to follow SAMHSA cutoff levels?
Only if your program is subject to federal mandates (such as DOT-regulated testing). Non-regulated employers, treatment programs, and other organizations have flexibility to use products with different cutoffs, though many adopt SAMHSA thresholds as a defensible baseline.
Can a lower cutoff create more false positives?
A lower cutoff increases sensitivity, meaning it can detect lighter or older use — but it may also flag cross-reactive compounds or trace exposures that a higher cutoff would not. This is one reason presumptive non-negative results from instant screens are typically sent to a lab for confirmation before any adverse action is taken.
How do I find the cutoff for a specific Magenta product?
Cutoff levels are stated on each product's package insert and product page. Because cutoffs can vary even within the same drug class across different SKUs, always verify the cutoff for the specific product you are purchasing rather than assuming a standard value.
Do oral fluid (saliva) drug tests use the same cutoffs as urine tests?
No. Oral fluid tests operate under different cutoff standards than urine tests. SAMHSA cutoff guidelines are defined specifically for urine specimens. Always consult the manufacturer's package insert for the cutoff levels that apply to any saliva-based product.